To determine the specificity and molecular features of such T cells expressing activation markers ex vivo, we directly sorted CD38+HLA-DR+PD-1+ CD8+ memory T cells from 21 matched patients with severe COVID-19 illness and performed single-cell transcriptome and TCR sequence analysis of >20,000 cells (fig. This evidence concerns the gene CD38 and COVID-19.